Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
Today's Highlight's Include: US expected to authorize mix-and-match COVID booster shots, White House details plans to vaccinate 28M children age 5-11, and Facebook is reportedly changing its name.
In this episode of Lab Medicine Rounds, Joseph Yao, M.D., Associate Professor of Laboratory Medicine and Pathology and Medicine, and Assistant Professor of Microbiology at the Mayo Clinic, discusses lessons learned from navigating the current COVID-19 pandemic.
PACE / State of CA / State of FLIn this month’s “Virtual Lecture,” Michael Camilleri, M.D., discusses the leaky gut, helping to understand components of the intestinal barrier, how to measure its permeability, review literature about effects that stress and diet have on permeability, and takes a futuristic look at barrier disfunction in the context of inflammatory bowel disease.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. As cases of COVID-19 fall in some areas of the country and rise in others, Dr. Morice and Dr. Pritt review where the pandemic stands, and emphasize that now is not the time to let our guard down.
Cynthia Collie, a hospital account executive for Mayo Clinic Laboratories, focuses on connecting her clients with the right people, tools, and services to meet their needs and goals.
This week’s research roundup features: Autopsy validation of progressive supranuclear palsy-predominant speech/language disorder criteria.
In part three of the 50th Anniversary series, Mayo Clinic Laboratories looks further outside the walls of Mayo Clinic. With the belief that the latest in diagnostic testing should be available to any patient, no matter where they are located, the sales force was born.
Topic's Include: Covid Queries: Altered DNA and microchips, Mayo Clinic Minute: Flu during a pandemic, and COVID-19 media only news briefing: Kids, COVID-19 and fall festivities / tips for staying safe.
Today's Highlight's Include: Walz to announce plans Friday morning to address hospital capacity, expanding COVID rapid testing, hospitals brace for an onslaught this winter, from flu as well as COVID, and Mayo announces urgent need for O+ and O- blood types.
It can be hard to know when to use a rapid at-home COVID-19 test and how to interpret the results. Dr. Binnicker reviews the pros and cons of these tests, and explains when you need to get tested by a lab.
In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity and 100% specificity. This is the first assay of its kind that can detect viral antigens “directly from clinical specimens” such as nasopharyngeal swabs. Mass spectrometry is a sensitive technique used to detect, identify, and quantitate molecules present in a sample.
This week’s research roundup features: Effect of urate-elevating inosine on early Parkinson disease progression: The SURE-PD3 randomized clinical trial.
Topic's Include: COVID-19 media only news briefing: What we know so far about post-COVID syndrome, Mayo Clinic Q&A podcast: The case for continuing COVID-19 precautions, and COVID queries: The speed of vaccine development.